Polk City, IA, United States of America

Shawn Baier

This inventor holds 19 USPTO granted patents and 19 published patent applications, plus 7 CIPO patents and 7 EPO patents, primarily in Nutritional Biochemistry. Top assignees: Metabolic Technologies, Inc., Tsi Group Co., Ltd., Metaolic Technologies, LLC. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shawn Baier. Retrieved from https://idiyas.com/inventor/shawn-baier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Adenosine Triphosphate
HMB
Muscular Function
Strength Recovery
Autophagy
Lipophagy
Nutritional Intervention
Fat Mass Reduction
19 patents (USPTO):Explore Patents

Title: **Shawn Baier: Innovator in Nutritional Sciences**

Introduction

Shawn Baier, based in Polk City, Iowa, stands out as a prominent inventor with a remarkable portfolio of 19 patents. His innovative contributions primarily focus on enhancing nutritional compositions and therapeutic methods. Through his work, Baier has significantly impacted the fields of nutrition and health, blending science with practicality.

Latest Patents

Among his notable achievements are two patents that address critical challenges in nutritional bioavailability. The first patent details "Compositions containing adenosine triphosphate (ATP) and methods of use." This invention provides a composition that leverages ATP as an absorption enhancer when combined with various nutritional materials, including proteins, vitamins, and minerals. It also outlines sophisticated methods for administering ATP or adenosine to improve the bioavailability of these materials.

The second patent focuses on "Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy." This invention describes a composition that includes HMB and outlines methods for its administration to animals. The patent highlights HMB's role in modulating autophagy and lipophagy, essential processes that can treat, prevent, or reduce conditions mediated by autophagy.

Career Highlights

Shawn Baier has had a notable career trajectory, working with leading companies in the biochemical and nutritional research sectors. Notable among these are Metabolic Technologies, Inc. and Tsi Group Company. His work with these organizations has allowed him to push the boundary of knowledge in nutritional sciences, resulting in patents that hold the potential to revolutionize dietary supplements and therapeutic approaches.

Collaborations

Throughout his career, Baier has collaborated with esteemed professionals in the field. Noteworthy colleagues include John Rathmacher and Naji N Abumrad, with whom he has likely shared insights and knowledge that further propelled innovative research and development.

Conclusion

Shawn Baier exemplifies the spirit of innovation through his extensive contributions to nutritional sciences. His patents not only advance scientific understanding but also hold promise for real-world applications in health and wellness. As he continues to develop new ideas and solutions, the impact of his work will undoubtedly resonate within the fields of nutrition and health for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…